FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3125330892> ?p ?o ?g. }

• W3125330892 endingPage "536" @default.
• W3125330892 startingPage "528" @default.
• W3125330892 abstract "Emerging evidence indicates that microRNAs (miRNAs) play a critical role in breast cancer development. We recently reported that a higher expression of miR-374b in tumor tissues was associated with a better disease-free survival of triple-negative breast cancer (TNBC). However, the functional significance and molecular mechanisms underlying the role of miR-374b in breast cancer are largely unknown. In this current study, we evaluated the biological functions and potential mechanisms of miR-374b in both TNBC and non-TNBC. We found that miR-374b was significantly downregulated in breast cancer tissues, compared to adjacent tissues. MiR-374b levels were also lower in breast cancer cell lines, as compared to breast epithelial cells. In vitro and in vivo studies demonstrated that miR-374b modulates the malignant behavior of breast cancer cells, such as cell proliferation in 2D and 3D, cell invasion ability, colony-forming ability and tumor growth in mice. By using bioinformatics tools, we predicted that miR-374b plays a role in breast cancer cells through negatively regulating cyclin D1 (CCND1) and transforming growth factor alpha (TGFA). We further confirmed that CCND1 and TGFA contribute to the malignant behavior of breast cancer cells in vitro and in vivo. Our rescue experiments showed that overexpressing CCND1 or TGFA reverses the phenotypes caused by miR-374b overexpression. Taken together, our studies suggest that miR-374b modulates malignant behavior of breast cancer cells by negatively regulating CCND1 and TGFA genes. The newly identified miR-374b-mediated CCND1 and TGFA gene silencing may facilitate a better understanding of the molecular mechanisms of breast cancer progression." @default.
• W3125330892 created "2021-02-01" @default.
• W3125330892 creator A5004617785 @default.
• W3125330892 creator A5005513706 @default.
• W3125330892 creator A5013962209 @default.
• W3125330892 creator A5019390307 @default.
• W3125330892 creator A5021293751 @default.
• W3125330892 creator A5039347763 @default.
• W3125330892 creator A5044730828 @default.
• W3125330892 creator A5049880729 @default.
• W3125330892 creator A5085657415 @default.
• W3125330892 date "2021-01-22" @default.
• W3125330892 modified "2023-10-16" @default.
• W3125330892 title "MicroRNA-374b inhibits breast cancer progression through regulating <i>CCND1</i> and <i>TGFA</i> genes" @default.
• W3125330892 cites W1965371218 @default.
• W3125330892 cites W1976324983 @default.
• W3125330892 cites W1978944350 @default.
• W3125330892 cites W1981122694 @default.
• W3125330892 cites W1994517409 @default.
• W3125330892 cites W1994930469 @default.
• W3125330892 cites W2008945738 @default.
• W3125330892 cites W2010196130 @default.
• W3125330892 cites W2022322735 @default.
• W3125330892 cites W2023444929 @default.
• W3125330892 cites W2046930479 @default.
• W3125330892 cites W2047529648 @default.
• W3125330892 cites W2050869737 @default.
• W3125330892 cites W2056302937 @default.
• W3125330892 cites W2056307371 @default.
• W3125330892 cites W2059382687 @default.
• W3125330892 cites W2069871721 @default.
• W3125330892 cites W2070933716 @default.
• W3125330892 cites W2071607446 @default.
• W3125330892 cites W2078702667 @default.
• W3125330892 cites W2105497479 @default.
• W3125330892 cites W2119040192 @default.
• W3125330892 cites W2123250471 @default.
• W3125330892 cites W2127207727 @default.
• W3125330892 cites W2128782161 @default.
• W3125330892 cites W2138473891 @default.
• W3125330892 cites W2149785901 @default.
• W3125330892 cites W2162674813 @default.
• W3125330892 cites W2163199119 @default.
• W3125330892 cites W2165183041 @default.
• W3125330892 cites W2169948124 @default.
• W3125330892 cites W2333972433 @default.
• W3125330892 cites W2766676715 @default.
• W3125330892 cites W3023299375 @default.
• W3125330892 cites W569789217 @default.
• W3125330892 doi "https://doi.org/10.1093/carcin/bgab005" @default.
• W3125330892 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8086770" @default.
• W3125330892 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33480984" @default.
• W3125330892 hasPublicationYear "2021" @default.
• W3125330892 type Work @default.
• W3125330892 sameAs 3125330892 @default.
• W3125330892 citedByCount "8" @default.
• W3125330892 countsByYear W31253308922022 @default.
• W3125330892 countsByYear W31253308922023 @default.
• W3125330892 crossrefType "journal-article" @default.
• W3125330892 hasAuthorship W3125330892A5004617785 @default.
• W3125330892 hasAuthorship W3125330892A5005513706 @default.
• W3125330892 hasAuthorship W3125330892A5013962209 @default.
• W3125330892 hasAuthorship W3125330892A5019390307 @default.
• W3125330892 hasAuthorship W3125330892A5021293751 @default.
• W3125330892 hasAuthorship W3125330892A5039347763 @default.
• W3125330892 hasAuthorship W3125330892A5044730828 @default.
• W3125330892 hasAuthorship W3125330892A5049880729 @default.
• W3125330892 hasAuthorship W3125330892A5085657415 @default.
• W3125330892 hasBestOaLocation W31253308922 @default.
• W3125330892 hasConcept C104317684 @default.
• W3125330892 hasConcept C119056186 @default.
• W3125330892 hasConcept C121608353 @default.
• W3125330892 hasConcept C125555471 @default.
• W3125330892 hasConcept C145059251 @default.
• W3125330892 hasConcept C199835354 @default.
• W3125330892 hasConcept C2779438470 @default.
• W3125330892 hasConcept C2780110267 @default.
• W3125330892 hasConcept C29537977 @default.
• W3125330892 hasConcept C502942594 @default.
• W3125330892 hasConcept C530470458 @default.
• W3125330892 hasConcept C54355233 @default.
• W3125330892 hasConcept C86803240 @default.
• W3125330892 hasConceptScore W3125330892C104317684 @default.
• W3125330892 hasConceptScore W3125330892C119056186 @default.
• W3125330892 hasConceptScore W3125330892C121608353 @default.
• W3125330892 hasConceptScore W3125330892C125555471 @default.
• W3125330892 hasConceptScore W3125330892C145059251 @default.
• W3125330892 hasConceptScore W3125330892C199835354 @default.
• W3125330892 hasConceptScore W3125330892C2779438470 @default.
• W3125330892 hasConceptScore W3125330892C2780110267 @default.
• W3125330892 hasConceptScore W3125330892C29537977 @default.
• W3125330892 hasConceptScore W3125330892C502942594 @default.
• W3125330892 hasConceptScore W3125330892C530470458 @default.
• W3125330892 hasConceptScore W3125330892C54355233 @default.
• W3125330892 hasConceptScore W3125330892C86803240 @default.
• W3125330892 hasFunder F4320309601 @default.
• W3125330892 hasFunder F4320321001 @default.
• W3125330892 hasFunder F4320332161 @default.

• next